{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "9327734",
  "DateCompleted": {
    "Year": "1997",
    "Month": "10",
    "Day": "30"
  },
  "DateRevised": {
    "Year": "2018",
    "Month": "12",
    "Day": "01"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "0002-9440",
      "JournalIssue": {
        "Volume": "151",
        "Issue": "4",
        "PubDate": {
          "Year": "1997",
          "Month": "Oct"
        }
      },
      "Title": "The American journal of pathology",
      "ISOAbbreviation": "Am J Pathol"
    },
    "ArticleTitle": "Respiratory infection in lipid-fed rabbits enhances sudanophilia and the expression of VCAM-1.",
    "Pagination": {
      "StartPage": "1009",
      "EndPage": "1017",
      "MedlinePgn": "1009-17"
    },
    "Abstract": {
      "AbstractText": [
        "The pathogenesis of atherosclerosis has been related to infection of the arterial wall, but it is not clear whether this occurs before or after the development of lipid-containing lesions. Respiratory bacterial infection increases the expression of vascular cell adhesion molecule-1 (VCAM-1). We therefore examined whether a similar infection would enhance atherosclerosis in New Zealand White rabbits fed chow supplemented by 15% (w/w) egg yolk for 50 days. Rabbits with naturally acquired respiratory infection by Pasteurella multocida, pathogen-free (SPF) animals infected by P. multocida in the laboratory, and age-matched SPF rabbits maintained in a disease-free environment were used. Endothelial cells expressing VCAM-1 in the aorta between intercostal arteries 3 and 5 were identified using anti-VCAM-1 (Rb1/9) and an alkaline-phosphatase-linked secondary antibody and quantified in H\u00e4utchen preparations. The remainder of the aorta was stained with Sudan IV to show lipid deposition. The expression of VCAM-1 (mean +/- SEM per 10,000 cells) was 22 +/- 8 (n = 5) in the lipid-fed SPF rabbits, significantly different from that in the lipid-fed rabbits with naturally occurring infection (190 +/- 51 (n = 5)) or from rabbits infected in the laboratory (106 +/- 25 (n = 5)). The extent of Sudanophilia was significantly greater in the naturally infected rabbits (8.3 +/- 1.2%) or infected SPF rabbits (10.3 +/- 1.8%) than in the SPF rabbits (2.7 +/- 0.8%; P < 0.05). Antibiotic treatment in naturally infected rabbits reduced the number of cells expressing VCAM-1 and the extent of the Sudanophilia to baseline levels. Thus, Sudanophilia is enhanced by bacterial infection in rabbits fed egg yolk and is associated with a significant increase in VCAM-1."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Pathology, McMaster University, Hamilton, Ontario, Canada."
          }
        ],
        "LastName": "Richardson",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "De Reske",
        "ForeName": "M",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Delaney",
        "ForeName": "K",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Fletch",
        "ForeName": "A",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Wilcox",
        "ForeName": "L H",
        "Initials": "LH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kinlough-Rathbone",
        "ForeName": "R L",
        "Initials": "RL"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Am J Pathol",
    "NlmUniqueID": "0370502",
    "ISSNLinking": "0002-9440"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Infective Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Azo Compounds"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Coloring Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Dietary Fats"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Fluoroquinolones"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Quinolones"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Vascular Cell Adhesion Molecule-1"
    },
    {
      "RegistryNumber": "3DX3XEK1BN",
      "NameOfSubstance": "Enrofloxacin"
    },
    {
      "RegistryNumber": "97C5T2UQ7J",
      "NameOfSubstance": "Cholesterol"
    },
    {
      "RegistryNumber": "I35E9QU96C",
      "NameOfSubstance": "Scarlet Red"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Anti-Infective Agents"
    },
    {
      "QualifierName": [
        "metabolism",
        "ultrastructure"
      ],
      "DescriptorName": "Aorta, Thoracic"
    },
    {
      "QualifierName": [
        "etiology",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Arteriosclerosis"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Azo Compounds"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Count"
    },
    {
      "QualifierName": [
        "blood"
      ],
      "DescriptorName": "Cholesterol"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Coloring Agents"
    },
    {
      "QualifierName": [
        "adverse effects"
      ],
      "DescriptorName": "Dietary Fats"
    },
    {
      "QualifierName": [
        "metabolism"
      ],
      "DescriptorName": "Endothelium, Vascular"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Enrofloxacin"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Fluoroquinolones"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Pasteurella Infections"
    },
    {
      "QualifierName": [
        "pathogenicity"
      ],
      "DescriptorName": "Pasteurella multocida"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology",
        "metabolism",
        "pathology"
      ],
      "DescriptorName": "Pneumonia, Bacterial"
    },
    {
      "QualifierName": [
        "pharmacology"
      ],
      "DescriptorName": "Quinolones"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rabbits"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Specific Pathogen-Free Organisms"
    },
    {
      "QualifierName": [
        "biosynthesis",
        "immunology"
      ],
      "DescriptorName": "Vascular Cell Adhesion Molecule-1"
    }
  ]
}